{
    "Trade/Device Name(s)": [
        "FreeStyle InsuLinx Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Abbott Laboratories",
    "510(k) Number": "K111874",
    "Predicate Device Reference 510(k) Number(s)": [
        "K020866"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR"
    ],
    "Summary Letter Date": "February 14, 2012",
    "Summary Letter Received Date": "February 15, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [
        "Fingertip collection"
    ],
    "Instrument(s)/Platform(s)": [
        "FreeStyle InsuLinx Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Coulometric biosensor",
        "Electrochemical measurement"
    ],
    "Methodologies": [
        "Glucose Dehydrogenase (GDH)-based electrochemical detection"
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Software",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for FreeStyle InsuLinx Blood Glucose Monitoring System utilizing coulometric biosensor technology for self-testing of glucose in capillary whole blood",
    "Indications for Use Summary": "Intended for the quantitative measurement of glucose in fresh capillary whole blood from the fingertip for self-testing by people with diabetes at home to monitor diabetes control; not for diagnosis, screening, or neonatal use",
    "fda_folder": "Clinical Chemistry"
}